Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 63c; Boosts FY14 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Gilead Sciences (GILD) PT Raised to $111 at Piper Jaffray Post Q2
July 24, 2014 10:40 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Gilead Sciences (NASDAQ: GILD) to $111.00 (from $106.00) following better-than-expected Q2 results and outlook.
Schimmer commented, "Yet again, GILD easily surpassed top/bottom line numbers but contracted LT growth... More
Gilead Sciences (GILD) PT Lifted to $165 at BMO Capital on Strong Q2
July 24, 2014 6:40 AM EDTBMO Capital analyst Jim Birchenough, M.D.boosted his price target on Outperform-rated Gilead Sciences (NASDAQ: GILD) to $165.00 (from $120.00) following Q2 results.
Birchenough comments, "With SOVALDI continuing to set sales records on a background of incomplete insurance coverage in the U.S.,... More
About 9,000 Hep C patients have been cured with Sovaldi to date - Gilead (GILD)
July 23, 2014 4:48 PM EDTGilead Sciences (NASDAQ: GILD) said about 9,000 Hep C patients have been cured with Sovaldi to date
... MoreGilead Sciences (GILD) to Resume Trading at 4:25PM ET Following Strong Results
July 23, 2014 4:22 PM EDTGilead Sciences (NASDAQ: GILD) set to resume trading at 4:25PM ET following strong Q2 results and outlook.
... MoreGilead Sciences (GILD) trading halted with news pending
July 23, 2014 4:04 PM EDTGilead Sciences (NASDAQ: GILD) trading halted with news pending.
... More